There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Investing in Testing Act of 2017

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To require the Director of the Centers for Disease Control and Prevention to complete a study on the human health implications of per- and polyfluoroalkyl substances (PFAS) contamination in drinking water.


Actions Overview (1)

Date
03/02/2017Introduced in House

All Actions (3)

Date
03/17/2017Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
03/02/2017Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
03/02/2017Introduced in House
Action By: House of Representatives

Cosponsors (0)

No cosponsors.


Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce03/02/2017 Referred to
House Energy and Commerce Subcommittee on Health03/17/2017 Referred to

No related bill information was received for H.R.1348.


Latest Summary (1)

There is one summary for H.R.1348. View summaries

Shown Here:
Introduced in House (03/02/2017)

Investing in Testing Act of 2017

This bill requires the Centers for Disease Control and Prevention to study the health implications of contamination of drinking water by perfluoroalkyl and polyfluoroalkyl substances (PFASs). (PFASs can accumulate in the body and are commonly found at low levels in food, water, and the environment.)